U.S. healthcare stocks may be about to benefit from the normalization of demand for health services as the pandemic winds down. John Stoltzfus of Oppenheimer Asset Management explains why biotechnology ‘offers upside’ within the sector pic.twitter.com/cXooQKDazk— Reuters (@Reuters) February 22, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


